424B51ea183657-424b5_boqiihold.htmPROSPECTUSSUPPLEMENT FiledpursuanttoRule424(b)(5)RegistrationNo.333-267919 AMENDMENTNO.1DATEDAUGUST16,2023 TOPROSPECTUSSUPPLEMENTDATEDJULY28,2023 (ToprospectusdatedNovember15,2022) BoqiiHoldingLimited Upto$7,035,000ofAmericanDepositaryShares Thisamendmentno.1toprospectussupplementamendsourprospectussupplementdatedJuly28,2023.ThisamendmentshouldbereadinconjunctionwiththeprospectussupplementandtheprospectusdatedNovember15,2022(FileNo.333-267919)andisqualifiedbyreferencethereto,excepttotheextentthattheinformationhereinamendsorsupersedestheinformationcontainedintheprospectussupplementortheprospectus.Thisamendmentisnotcompletewithout,andmayonlybedeliveredorutilizedinconnectionwith,theprospectussupplementandtheprospectus,andanyfutureamendmentsorsupplementsthereto. Wehaveenteredintoasecuritiespurchaseagreement,datedJuly28,2023,withVGMasterFundSPC(“VG”),asamendedbyanamendmenttothesecuritiespurchaseagreementdatedAugust16,2023(thesecuritiespurchaseagreement,asamended,the“PurchaseAgreement”),pursuanttowhichwemayselltoVG,fromtimetotime,(i)upto$7,000,000ofourAmericandepositoryshares(the“ADSs”,eachADSrepresenting4.5ClassAordinaryshares,parvalue$0.001pershare,oftheCompany(the“PurchaseShares”)and(ii)upto$35,000ofourADSsbeingissuedtoVGascommitmentshares(the“CommitmentShares”). Upondeliveryofapurchasenotice,andsubjecttoourinstructionsinthatnoticeandthetermsandconditionsofthePurchaseAgreementgenerally,VGmaysellourADSsbyanymethodpermittedbylawdeemedtobean“atthemarketoffering”asdefinedbyRule415(a)(4)promulgatedundertheSecuritiesActof1933,asamended(the“SecuritiesAct”),including(A)inprivatelynegotiatedtransactionswithourpriorwrittenconsent;(B)asblocktransactions;or(C)byanyothermethodpermittedbylawdeemedtobean“atthemarketoffering,”includingsalesmadedirectlyontheNYSEorsalesmadeintoanyotherexistingtradingmarketforourADSs.Thereisnoarrangementforfundstobereceivedinanyescrow,trustorsimilararrangement. Duringthe12calendarmonthspriorto,andincluding,thedateofthisamendmenttotheprospectussupplement,wehavenotsoldanysecuritiespursuanttoGeneralInstructionI.B.5ofFormF-3. Investinginoursecuritiesinvolvesrisks.Beforebuyinganysecurities,youshouldcarefullyconsidertherisksthatwehavedescribedin“SupplementalRiskFactors”beginningonpage2ofthisamendmenttotheprospectussupplementandpageS-17oftheprospectussupplement,aswellasthosedescribedinourfilingsundertheSecuritiesExchangeActof1934,asamended(the“ExchangeAct”). NeithertheSecuritiesandExchangeCommissionnoranystatesecuritiescommissionhasapprovedordisapprovedofthesesecuritiesordeterminedifthisamendmenttotheprospectussupplement,theprospectussupplementortheprospectusistruthfulorcomplete.Anyrepresentationtothecontraryisacriminaloffense. ThedateofthisamendmenttotheprospectussupplementisAugust16,2023 TableofContents THEOFFERING1 SUPPLEMENTALRISKFACTORS2 PLANOFDISTRIBUTION7 DILUTION4 VGTRANSACTION5 i TheOffering Securitiesofferedbyus.Upto$7,000,000ofADSswemayissueandselltoVGfrom timetotimeoverthenext12months,atoursolediscretion,inaccordancewiththePurchaseAgreement,andanadditional $35,000ofADSs,subjecttocertainadjustments(See“VGTransaction—General”inthisprospectussupplement),tobeissuedtoVGasconsiderationforitscommitmenttopurchaseADSsunderthePurchaseAgreement(the“CommitmentShares”).WewillnotreceiveanycashproceedsfromtheissuanceoftheseCommitmentShares. ADSsoutstandingimmediatelyprior tothisoffering15,717,663ADSs. ADSstobeoutstandingafterthisofferingiscompleted 21,693,854ADSs,assumingsaleof5,952,381ADSs(basedon $7,000,000ofADSsatanassumedofferingpriceof$1.18perADS,whichis80%of$1.47,thelastreportedsalepriceofourADSsontheNYSEonJuly27,2023),andassuminganissuanceofadditional23,810ADSs,subjecttocertainadjustments(See“VGTransaction—General”inthisprospectussupplement)asCommitmentShares(basedon $35,000ofADSsatthe$1.47priceperADS,whichistheclosingpriceofourADSsontheNYSEonJuly27,2023,thebusinessdaypriortotheexecutionofthePurchaseAgreement).TheactualtotalnumberofADSsissuedwillvarydependingonthesalespricesunderthisofferingandcertainadjustmentsunderthePurchaseAgreement. UseofproceedsWeintendtousethenetproceedsofthisofferingforgeneralcorporateandworkingcapitalpurposes.See“UseofProceeds”onpageS-3oftheprospectussupplement. MarketfortheADSsOurADSsaretradedontheNYSEunderthesymbol“BQ.” RiskfactorsSee“SupplementalRiskFactors”beginningonpage2ofthisamendmenttotheprospectussupplementandpageS-17oftheprospectussupplementand“RiskFactors”beginningonpage34oftheprospectusandinthedocumentsincorporatedbyreferenceherein(including“RiskFactors”inourmostrecentAnnualReportonForm20-F)andundersimilarheadingsintheotherdocumentsthatareincorporatedbyreferenceherein,aswellastheotherinformationincludedinorincorporatedbyreferenceinthisamendmenttotheprospectussupplement,theprospectussupplementandtheprospectusforadiscussionoftherisksyoushouldcarefullyconsiderbeforedecidingtoinvestinoursecurities. 1 SupplementalRiskFactors Investinginoursecuritiesinvolvesahighdegreeofrisk.Beforeinvestinginoursecurities,youshouldcarefullyconside